CA2293408A1 - Alpha 1a adrenergic receptor antagonists - Google Patents
Alpha 1a adrenergic receptor antagonists Download PDFInfo
- Publication number
- CA2293408A1 CA2293408A1 CA002293408A CA2293408A CA2293408A1 CA 2293408 A1 CA2293408 A1 CA 2293408A1 CA 002293408 A CA002293408 A CA 002293408A CA 2293408 A CA2293408 A CA 2293408A CA 2293408 A1 CA2293408 A1 CA 2293408A1
- Authority
- CA
- Canada
- Prior art keywords
- pyrrolidin
- phenyl
- cyclohexyl
- carboxylic acid
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4992197P | 1997-06-18 | 1997-06-18 | |
| US60/049,921 | 1997-06-18 | ||
| GBGB9719392.4A GB9719392D0 (en) | 1997-09-11 | 1997-09-11 | Alpha la adrenergic receptor antagonists |
| GB9719392.4 | 1997-09-11 | ||
| PCT/US1998/012673 WO1998057641A1 (en) | 1997-06-18 | 1998-06-17 | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2293408A1 true CA2293408A1 (en) | 1998-12-23 |
Family
ID=26312232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002293408A Abandoned CA2293408A1 (en) | 1997-06-18 | 1998-06-17 | Alpha 1a adrenergic receptor antagonists |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0998285A4 (ja) |
| JP (1) | JP2002505684A (ja) |
| AU (1) | AU734892B2 (ja) |
| CA (1) | CA2293408A1 (ja) |
| WO (1) | WO1998057641A1 (ja) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6207444B1 (en) | 1997-08-05 | 2001-03-27 | Merck & Co., Inc. | Enzymatic process of making alpha 1a adrenergic receptor antagonists using protease |
| US6410554B1 (en) | 1998-03-23 | 2002-06-25 | Merck & Co., Inc. | Combination therapy for the treatment of benign prostatic hyperplasia |
| WO2000006565A1 (en) | 1998-07-30 | 2000-02-10 | Merck & Co., Inc. | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| US6228870B1 (en) | 1998-11-10 | 2001-05-08 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1a adrenoceptor antagonists |
| US6319932B1 (en) | 1998-11-10 | 2001-11-20 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1A adrenoceptor antagonists |
| US6358959B1 (en) | 1999-01-26 | 2002-03-19 | Merck & Co., Inc. | Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists |
| US6828460B2 (en) | 1999-03-22 | 2004-12-07 | Pfizer Inc. | Resorcinol derivatives |
| GB2355456A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| GB2355457A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists |
| GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
| GB2355263A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
| EP1565436B1 (en) | 2002-11-27 | 2012-04-25 | Incyte Corporation | 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| US7166603B2 (en) | 2003-07-23 | 2007-01-23 | Bristol-Myers Squibb Co. | Dihydropyrimidone inhibitors of calcium channel function |
| PE20110928A1 (es) | 2008-12-10 | 2012-01-05 | Janssen Pharmaceutica Nv | Derivados de 4-azetidinil-1-heteroaril-ciclohexanol como antagonistas de ccr2 |
| AU2010236346B2 (en) | 2009-04-17 | 2015-01-22 | Janssen Pharmaceutica Nv | 4-azetidinyl-1-phenyl-cyclohexane antagonists of CCR2 |
| BRPI1016205A2 (pt) | 2009-04-17 | 2016-04-19 | Janssen Pharmaceutica Nv | compostos de cicloexano ligado a 4-azetidinil-1-heteroátomo antagonistas de ccr2 |
| AR081587A1 (es) | 2010-06-09 | 2012-10-03 | Janssen Pharmaceutica Nv | DERIVADOS DE 5,6-DIHIDRO-2H-[1,4]OXAZIN-3-IL-AMINA UTILES COMO INHIBIDORES DE LA b-SECRETASA (BACE) |
| TW201211027A (en) * | 2010-06-09 | 2012-03-16 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| US8518969B2 (en) | 2010-06-17 | 2013-08-27 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| KR101866987B1 (ko) | 2010-12-22 | 2018-07-19 | 얀센 파마슈티카 엔.브이. | 베타-세크레타아제(ＢＡＣＥ) 저해제로 유용한 5,6-디하이드로-이미다조[1,2-ａ]피라진-8-일-아민 유도체 |
| SG193342A1 (en) | 2011-03-09 | 2013-10-30 | Janssen Pharmaceutica Nv | 3,4-DIHYDRO-PYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) |
| ES2619829T3 (es) | 2011-11-18 | 2017-06-27 | Heptares Therapeutics Limited | Agonistas del receptor muscarínico M1 |
| CA2912156C (en) | 2013-06-12 | 2021-07-20 | Janssen Pharmaceutica Nv | 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazin-3(2h)-one derivatives as inhibitors of beta-secretase (bace) |
| BR112015030597A2 (pt) | 2013-06-12 | 2017-07-25 | Janssen Pharmaceutica Nv | derivados 4-amino-6-fenil-6,7-di-hidro[1,2,3]triazolo[1,5-a]pirazina como inibidores de beta-secretase (bace) |
| AU2014280124B2 (en) | 2013-06-12 | 2018-11-01 | Janssen Pharmaceutica Nv | 4-amino-6-phenyl-5,6-dihydroimidazo[1,5-a]pyrazine derivatives as inhibitors of beta-secretase (BACE) |
| MX2017008083A (es) | 2014-12-18 | 2017-10-31 | Janssen Pharmaceutica Nv | Compuestos 2,3,4,5-tetrahidropiridin-6-amina y 3,4-dihidro-2h-pirrol-5-amina inhibidores de beta-secretasa. |
| US10259787B2 (en) | 2016-10-14 | 2019-04-16 | Heptares Therapeutics Limited | Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4049821A (en) * | 1976-05-12 | 1977-09-20 | A. H. Robins Company, Inc. | Method of treating allergy |
| US4109005A (en) * | 1977-05-11 | 1978-08-22 | A. H. Robins Company, Inc. | Method of increasing rate of gastric emptying with pyrrolidinylbenzamides |
| US4254135A (en) * | 1979-10-16 | 1981-03-03 | A. H. Robins Company, Inc. | 3-Amino-4-hydroxypyrrolidines |
| US5124457A (en) * | 1986-05-21 | 1992-06-23 | Abbott Laboratories | Phencyclidine and phencyclidine metabolites assay, tracers, immunogens and antibodies |
| US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
| KR970706823A (ko) * | 1994-11-16 | 1997-12-01 | 멀닉스 캐슬린 피. | 디히드로피리미딘과 그 사용법(dihydropyrimidines and uses thereof) |
-
1998
- 1998-06-17 CA CA002293408A patent/CA2293408A1/en not_active Abandoned
- 1998-06-17 AU AU79763/98A patent/AU734892B2/en not_active Ceased
- 1998-06-17 WO PCT/US1998/012673 patent/WO1998057641A1/en not_active Application Discontinuation
- 1998-06-17 EP EP98930356A patent/EP0998285A4/en not_active Withdrawn
- 1998-06-17 JP JP50478199A patent/JP2002505684A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU734892B2 (en) | 2001-06-28 |
| EP0998285A4 (en) | 2003-01-08 |
| WO1998057641A1 (en) | 1998-12-23 |
| JP2002505684A (ja) | 2002-02-19 |
| EP0998285A1 (en) | 2000-05-10 |
| AU7976398A (en) | 1999-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2293408A1 (en) | Alpha 1a adrenergic receptor antagonists | |
| US5977115A (en) | Alpha 1a adrenergic receptor antagonists | |
| US6255315B1 (en) | Alpha 1a adrenergic receptor antagonists | |
| CA2294346A1 (en) | Alpha 1a adrenergic receptor antagonists | |
| US6358959B1 (en) | Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists | |
| WO1999025345A1 (en) | Alpha-1a adrenergic receptor antagonists | |
| US6316437B1 (en) | Spirohydantoin compounds and uses thereof | |
| CA2294344A1 (en) | Alpha 1a adrenergic receptor antagonists | |
| CA2294349A1 (en) | Alpha 1aadrenergic receptor antagonists | |
| CA2294590A1 (en) | Alpha 1a adrenergic receptor antagonists | |
| CA2294591A1 (en) | Alpha 1a adrenergic receptor antagonists | |
| US6080760A (en) | Alpha 1A adrenergic receptor antagonists | |
| US6143750A (en) | Alpha 1a adrenergic receptor antagonists | |
| US5807856A (en) | Alpha 1a adrenergic receptor antagonist | |
| US6376503B1 (en) | Alpha 1a adrenergic receptor antagonists | |
| US6326372B1 (en) | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists | |
| US6319932B1 (en) | Oxazolidinones useful as alpha 1A adrenoceptor antagonists | |
| US6057350A (en) | Alpha 1a adrenergic receptor antagonists | |
| GB2355457A (en) | Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists | |
| US6214832B1 (en) | Bis-piperidinyl-pyrimidin-2-ones as alpha 1a adrenergic receptor antagonists | |
| US6235759B1 (en) | Dihydropyridinones and pyrrolinones useful as alpha 1A adrenoceptor antagonists | |
| US5922722A (en) | Alpha 1a adrenergic receptor antagonists | |
| US6228870B1 (en) | Oxazolidinones useful as alpha 1a adrenoceptor antagonists | |
| WO2000027816A1 (en) | Oxazolidinones useful as alpha 1a adrenoceptor antagonists | |
| WO1997018209A1 (en) | ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |